ArticleDiscover oncology2026
Comparison of clinical characteristics between children and adults with adrenal mass.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveAdrenal mass (AM) is a common disease with severe health problems. Its pathogenesis is different in adults and children; therefore, this study compared the differences in the clinical characteristics of AM between adults and children.
methodsThis retrospective study collected the clinical data of participants from a pediatric and an adult institution between January 2015 and January 2025. The data primarily included gender, age, initial presentation, mass size, site of the mass, functional mass, surgery, and pathological diagnosis.
resultsA total of 1049 AM patients were analyzed in this study, including 811 (77.3%) adults and 238 (22.7%) children. Of 238 children, 141 (59.2%) were boys, and the median age of this cohort was 2.6 years. The most common AM was hematoma (52.1%), followed by neuroblastoma (28.2%) and ganglioneuroblastoma (9.7%). In 811 adults, including 402 (49.6%) male cases, the median age at initial diagnosis was 52 years. The common AM cases included adrenocortical adenoma (68.4%), pheochromocytoma (10.4%), and myeloid lipoma (7.6%). Compared to adults, children often showed a large-sized (> 4 cm) AM, which was less functional, benign masses. Furthermore, there were statistical differences between the two paired groups (p < 0.05). Similarly, 113 (47.5%) children and 713 (87.9%) adults underwent surgery. Most children (89, 78.8%) received open surgeries, while most adults (690, 96.7%) chose minimally invasive surgeries. It was found that most AMs were incidentally detected in both children and adults.
conclusionsThis study showed that in children, hematoma was the most common AM followed by neuroblastoma and ganglioneuroblastoma, whereas the most commonly detected AMs included adrenocortical adenoma, pheochromocytoma, and myeloid lipoma in adults. Furthermore, significant differences were observed in some clinical characteristics of children and adults with AM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.